Home | Sitemap | Contact | Directory | CAS | 中文
About Us News People Research Education & Training International Cooperation Societies & Publications Papers Resources Links Join Us
Int’l Cooperation News
· China's anti-COVID-19 drug enters late-stage human trial [2021-11-22]
· Deputy Prime Minister of Uzbekistan Behzod Musayev: China's COVID-19 Vaccine Safe and Effective [2021-09-26]
· IMCAS Hosts Meeting of Cryptogamic Flora of China to Celebrate the Centenary of the Founding of t... [2021-07-16]
· IMCAS Holds 2021 Graduation Ceremony [2021-07-08]
· IMCAS Honored Outstanding Contributions on Scientific Popularization for Anti-epidemic Work [2021-05-13]
· EMA Issues Advice on Lilly's Etesevimab (LY-CoV016) Developed by IMCAS and Junshi Biosciences tog... [2021-03-15]
· SHI Yi Awarded “Innovators Under 35 in China” for 2020 [2020-12-14]
· IMCAS Holds Unblinding Meeting of Phase I/II Clinical Trial of Recombinant Subunit Vaccines for C... [2020-11-06]
· 2020 Gaochun Summit for Biomedicine and Health Industry [2020-10-27]
· Memorandum of Understanding on Cooperation Between the Institute of Microbiology, Chinese Academy... [2020-09-07]
· [Chemical & Engineering News]Enzyme screen unlocks easier route to 2-ketoacids [2020-08-10]
· [CHINA DAILY] Vaccine enters phase 3 trial [2020-07-01]
· Virus Genome Sequence Data of COVID-19 Outbreak in Xinfadi, Beijing Released [2020-06-19]
· Mab against COVID-19 Developed by IMCAS Researchers Enters Clinical Trial [2020-06-08]
· [China Daily]Scientists to Seek More Cooperation on Virus Data Sharing [2020-04-13]
13 Page(s)12345Next下5页Final
Institute Of Microbiology Chinese Academy of Sciences
NO.1 West Beichen Road, Chaoyang District, Beijing 100101, China Phone: 0086-10-64807462 Fax: 0086-10-64807468 Email: office@im.ac.cn